| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.741 | 0.005 | 0.741 | Amyloid beta aggregation inhibitor | 0.448 0.019 CID_154699485 | ||
| 0.707 | 0.004 | 0.764 | Superoxide dismutase inhibitor | 0.764 0.003 CID_154699485 | CID_154699485 | |
| 0.705 | 0.008 | 0.705 | Aldehyde oxidase inhibitor | 0.243 0.085 CID_154699485 | ||
| 0.714 | 0.022 | 0.714 | Caspase 9 stimulant | 0.271 0.228 CID_154699485 | ||
| 0.687 | 0.005 | 0.687 | Free radical scavenger | 0.552 0.012 CID_154699485 | ||
| 0.649 | 0.008 | 0.649 | Antioxidant | 0.646 0.008 CID_154699485 | ||
| 0.649 | 0.01 | 0.649 | 12-Lipoxygenase inhibitor | 0.272 0.097 CID_154699485 | ||
| 0.66 | 0.037 | 0.66 | Apoptosis agonist | 0.488 0.078 CID_154699485 | ||
| 0.64 | 0.019 | 0.64 | 15-Lipoxygenase inhibitor | 0.538 0.033 CID_154699485 | ||
| 0.643 | 0.026 | 0.643 | Transcription factor NF kappa B inhibitor | 0.473 0.049 CID_154699485 | ||
| 0.608 | 0.009 | 0.608 | Histamine release inhibitor | 0.562 0.014 CID_154699485 | ||
| 0.596 | 0.01 | 0.596 | Lipoxygenase inhibitor | 0.284 0.079 CID_154699485 | ||
| 0.582 | 0.005 | 0.582 | P-glycoprotein inhibitor | 0.24 0.045 CID_154699485 | ||
| 0.585 | 0.011 | 0.585 | Caspase 3 stimulant | 0.21 0.155 CID_154699485 | ||
| 0.615 | 0.051 | 0.615 | Alpha-glucosidase inhibitor | 0.349 0.136 CID_154699485 | ||
| 0.562 | 0.006 | 0.562 | Monophenol monooxygenase inhibitor | 0.374 0.013 CID_154699485 | ||
| 0.566 | 0.016 | 0.566 | 5 Hydroxytryptamine release inhibitor | 0.258 0.218 CID_154699485 | ||
| 0.538 | 0.011 | 0.538 | Hypoxia-inducible factor 1 alpha inhibitor | 0.293 0.069 CID_154699485 | ||
| 0.515 | 0.008 | 0.515 | Peroxidase inhibitor | 0.328 0.032 CID_154699485 | ||
| 0.519 | 0.014 | 0.519 | Antiamyloidogenic | 0.229 0.082 CID_154699485 | ||
| 0.507 | 0.007 | 0.507 | Tubulin antagonist | 0.278 0.022 CID_154699485 | ||
| 0.524 | 0.024 | 0.524 | Vasodilator, peripheral | |||
| 0.503 | 0.005 | 0.503 | Breast cancer-resistant protein inhibitor | 0.48 0.005 CID_154699485 | ||
| 0.495 | 0.005 | 0.495 | 5 Hydroxytryptamine uptake stimulant | 0.228 0.106 CID_154699485 | ||
| 0.487 | 0.007 | 0.487 | Melanin inhibitor | 0.162 0.067 CID_154699485 | ||
| 0.479 | 0.004 | 0.479 | Neurotrophic factor enhancer | 0.193 0.083 CID_154699485 | ||
| 0.476 | 0.004 | 0.476 | NADPH oxidase inhibitor | |||
| 0.487 | 0.021 | 0.487 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.45 | 0.007 | 0.45 | Amylase inhibitor | 0.109 0.089 CID_154699485 | ||
| 0.452 | 0.011 | 0.452 | Transcription factor STAT3 inhibitor | 0.181 0.162 CID_154699485 | ||
| 0.45 | 0.014 | 0.45 | Pyruvate kinase inhibitor | 0.142 0.122 CID_154699485 | ||
| 0.453 | 0.023 | 0.453 | Vasodilator, coronary | 0.245 0.139 CID_154699485 | ||
| 0.435 | 0.013 | 0.435 | Transcription factor STAT inhibitor | |||
| 0.426 | 0.015 | 0.508 | RNA-directed DNA polymerase inhibitor | 0.508 0.01 CID_154699485 | CID_154699485 | |
| 0.428 | 0.022 | 0.428 | Nitric oxide antagonist | 0.286 0.043 CID_154699485 | ||
| 0.419 | 0.024 | 0.419 | Tumour necrosis factor alpha release inhibitor | 0.255 0.073 CID_154699485 | ||
| 0.398 | 0.006 | 0.398 | Tumour necrosis factor antagonist | 0.134 0.121 CID_154699485 | ||
| 0.399 | 0.008 | 0.399 | Tyrosine 3 hydroxylase inhibitor | 0.23 0.09 CID_154699485 | ||
| 0.409 | 0.022 | 0.409 | Antimitotic | 0.331 0.037 CID_154699485 | ||
| 0.414 | 0.034 | 0.414 | Apoptosis antagonist | 0.193 0.188 CID_154699485 | ||
| 0.384 | 0.005 | 0.384 | Cystathionine beta-synthase inhibitor | 0.112 0.065 CID_154699485 | ||
| 0.475 | 0.099 | 0.49 | Antiinflammatory | 0.49 0.092 CID_154699485 | CID_154699485 | |
| 0.373 | 0.011 | 0.373 | Lipid peroxidase inhibitor | 0.293 0.02 CID_154699485 | ||
| 0.365 | 0.005 | 0.365 | Succinate dehydrogenase inhibitor | 0.243 0.025 CID_154699485 | ||
| 0.363 | 0.004 | 0.363 | Nitric-oxide synthase stimulant | 0.211 0.071 CID_154699485 | ||
| 0.367 | 0.014 | 0.367 | DNA methylase inhibitor | |||
| 0.391 | 0.039 | 0.391 | Aryl hydrocarbon receptor agonist | |||
| 0.366 | 0.014 | 0.366 | MAO inhibitor | |||
| 0.363 | 0.012 | 0.363 | DNA methyltransferase I inhibitor | 0.136 0.121 CID_154699485 | ||
| 0.403 | 0.056 | 0.403 | Thioredoxin glutathione reductase inhibitor | |||
| 0.353 | 0.007 | 0.353 | 5-Lipoxygenase inhibitor | |||
| 0.448 | 0.101 | 0.448 | DNA polymerase beta inhibitor | |||
| 0.353 | 0.008 | 0.353 | Chelator | 0.092 0.089 CID_154699485 | ||
| 0.352 | 0.008 | 0.352 | Heat shock protein 90 alpha antagonist | |||
| 0.342 | 0.006 | 0.342 | Heat shock protein 90 antagonist | |||
| 0.34 | 0.004 | 0.34 | Farnesoid X receptor antagonist | 0.221 0.016 CID_154699485 | ||
| 0.338 | 0.004 | 0.338 | Mannose-6-phosphate isomerase inhibitor | 0.135 0.08 CID_154699485 | ||
| 0.355 | 0.023 | 0.355 | Anesthetic general | |||
| 0.343 | 0.014 | 0.343 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.367 | 0.039 | 0.367 | Calcium channel activator | |||
| 0.428 | 0.105 | 0.428 | DNA directed DNA polymerase inhibitor | |||
| 0.332 | 0.016 | 0.396 | Phospholipase C inhibitor | 0.396 0.011 CID_154699485 | CID_154699485 | |
| 0.357 | 0.05 | 0.357 | Spasmolytic | 0.242 0.095 CID_154699485 | ||
| 0.377 | 0.072 | 0.377 | GABA C receptor rho-3 antagonist | |||
| 0.31 | 0.006 | 0.31 | Beta glucuronidase inhibitor | 0.102 0.067 CID_154699485 | ||
| 0.409 | 0.106 | 0.409 | Transcription factor inhibitor | |||
| 0.36 | 0.059 | 0.36 | Streptokinase A inhibitor | |||
| 0.382 | 0.085 | 0.511 | Antibacterial | 0.511 0.037 CID_154699485 | CID_154699485 | |
| 0.364 | 0.068 | 0.364 | Thyroid hormone antagonist | |||
| 0.303 | 0.008 | 0.303 | Interleukin 4 antagonist | |||
| 0.311 | 0.018 | 0.311 | Interferon gamma antagonist | 0.127 0.117 CID_154699485 | ||
| 0.299 | 0.013 | 0.299 | MAO B inhibitor | |||
| 0.299 | 0.013 | 0.299 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.347 | 0.066 | 0.495 | Cholesterol antagonist | 0.495 0.033 CID_154699485 | CID_154699485 | |
| 0.324 | 0.045 | 0.324 | Hypoglycemic | |||
| 0.317 | 0.043 | 0.564 | Angiogenesis stimulant | 0.564 0.008 CID_154699485 | CID_154699485 | |
| 0.344 | 0.071 | 0.344 | Thyroid hormone beta antagonist | |||
| 0.278 | 0.005 | 0.278 | Beta tubulin antagonist | 0.073 0.033 CID_154699485 | ||
| 0.332 | 0.061 | 0.332 | 5 Hydroxytryptamine release stimulant | |||
| 0.268 | 0.005 | 0.419 | HIV-1 integrase (Strand Transfer) inhibitor | 0.419 0.004 CID_154699485 | CID_154699485 | |
| 0.265 | 0.005 | 0.265 | Macrophage migration inhibitory factor inhibitor | 0.091 0.041 CID_154699485 | ||
| 0.264 | 0.006 | 0.429 | HIV-1 integrase (3'-Processing) inhibitor | 0.429 0.004 CID_154699485 | CID_154699485 | |
| 0.319 | 0.063 | 0.319 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 CID_154699485 | ||
| 0.272 | 0.021 | 0.272 | Protein kinase stimulant | |||
| 0.265 | 0.016 | 0.316 | Cholesterol synthesis inhibitor | 0.316 0.01 CID_154699485 | CID_154699485 | |
| 0.335 | 0.088 | 0.335 | Prostaglandin dehydrogenase inhibitor | |||
| 0.274 | 0.028 | 0.274 | Mcl-1 antagonist | |||
| 0.281 | 0.035 | 0.301 | Hepatoprotectant | 0.301 0.029 CID_154699485 | CID_154699485 | |
| 0.302 | 0.057 | 0.302 | Insulysin inhibitor | |||
| 0.263 | 0.019 | 0.263 | MAO A inhibitor | |||
| 0.294 | 0.05 | 0.294 | Vasodilator | |||
| 0.28 | 0.04 | 0.469 | Platelet adhesion inhibitor | 0.469 0.007 CID_154699485 | CID_154699485 | |
| 0.256 | 0.018 | 0.256 | Interleukin 1 antagonist | |||
| 0.241 | 0.009 | 0.241 | Histidine decarboxylase inhibitor | |||
| 0.234 | 0.008 | 0.234 | Photosensitizer | 0.127 0.049 CID_154699485 | ||
| 0.237 | 0.012 | 0.237 | Toll-Like receptor 2 antagonist | |||
| 0.244 | 0.021 | 0.257 | Alkaline phosphatase inhibitor | 0.257 0.019 CID_154699485 | CID_154699485 | |
| 0.228 | 0.007 | 0.228 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.105 0.035 CID_154699485 | ||
| 0.26 | 0.039 | 0.26 | Non-steroidal antiinflammatory agent | |||
| 0.228 | 0.007 | 0.228 | HIV-1 integrase (Overall Integration) inhibitor | 0.14 0.029 CID_154699485 | ||
| 0.23 | 0.011 | 0.23 | Mediator release inhibitor | |||
| 0.221 | 0.003 | 0.221 | Granulocyte macrophage colony stimulating factor agonist | 0.118 0.017 CID_154699485 | ||
| 0.222 | 0.005 | 0.222 | Alpha tubulin antagonist | 0.088 0.017 CID_154699485 | ||
| 0.23 | 0.014 | 0.23 | Xanthine oxidase inhibitor | |||
| 0.23 | 0.016 | 0.23 | Neurotrophic factor | |||
| 0.221 | 0.008 | 0.221 | Vanilloid 1 agonist | 0.192 0.014 CID_154699485 | ||
| 0.216 | 0.005 | 0.216 | DOPA decarboxylase inhibitor | 0.101 0.074 CID_154699485 | ||
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.174 0.061 CID_154699485 | ||
| 0.263 | 0.057 | 0.263 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.215 | 0.01 | 0.215 | Mucolytic | 0.122 0.053 CID_154699485 | ||
| 0.221 | 0.017 | 0.221 | Expectorant | 0.099 0.069 CID_154699485 | ||
| 0.236 | 0.034 | 0.236 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.268 | 0.066 | 0.268 | Interleukin agonist | |||
| 0.208 | 0.008 | 0.208 | Keratolytic | |||
| 0.227 | 0.028 | 0.227 | Topoisomerase II inhibitor | 0.137 0.056 CID_154699485 | ||
| 0.269 | 0.071 | 0.269 | DNA damaging | |||
| 0.21 | 0.013 | 0.437 | Carbonic anhydrase XIII inhibitor | 0.437 0.004 CID_154699485 | CID_154699485 | |
| 0.223 | 0.027 | 0.223 | Acetylcholinesterase inhibitor | |||
| 0.203 | 0.01 | 0.203 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.093 CID_154699485 | ||
| 0.237 | 0.045 | 0.464 | Dual specificity phosphatase 3 inhibitor | 0.464 0.009 CID_154699485 | CID_154699485 | |
| 0.223 | 0.032 | 0.223 | Phospholipase A2 inhibitor | 0.174 0.057 CID_154699485 | ||
| 0.203 | 0.018 | 0.203 | Carbonic anhydrase XV inhibitor | 0.124 0.044 CID_154699485 | ||
| 0.224 | 0.039 | 0.397 | Protein-tyrosine phosphatase inhibitor | 0.397 0.009 CID_154699485 | CID_154699485 | |
| 0.214 | 0.03 | 0.214 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.224 | 0.045 | 0.459 | Dual specificity phosphatase inhibitor | 0.459 0.009 CID_154699485 | CID_154699485 | |
| 0.183 | 0.005 | 0.183 | Bile acid receptor antagonist | 0.177 0.005 CID_154699485 | ||
| 0.209 | 0.031 | 0.211 | Cyclooxygenase 1 inhibitor | 0.211 0.03 CID_154699485 | CID_154699485 | |
| 0.183 | 0.006 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_154699485 | ||
| 0.194 | 0.017 | 0.194 | Carbonic anhydrase III inhibitor | 0.16 0.025 CID_154699485 | ||
| 0.242 | 0.065 | 0.242 | Interleukin antagonist | |||
| 0.2 | 0.029 | 0.2 | GABA C receptor rho-2 antagonist | |||
| 0.185 | 0.015 | 0.185 | Phosphodiesterase IV inhibitor | |||
| 0.174 | 0.004 | 0.174 | D-Ala-D-Ala ligase inhibitor | 0.083 0.059 CID_154699485 | ||
| 0.188 | 0.02 | 0.188 | Adenylate cyclase stimulant | 0.179 0.027 CID_154699485 | ||
| 0.189 | 0.022 | 0.189 | Interleukin 1b antagonist | |||
| 0.215 | 0.049 | 0.215 | Histone acetyltransferase inhibitor | |||
| 0.188 | 0.023 | 0.188 | Microtubule formation inhibitor | |||
| 0.181 | 0.018 | 0.181 | Topoisomerase II alpha inhibitor | 0.07 0.061 CID_154699485 | ||
| 0.196 | 0.033 | 0.196 | Anesthetic local | |||
| 0.164 | 0.008 | 0.164 | Ornithine decarboxylase inhibitor | |||
| 0.161 | 0.005 | 0.161 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.16 | 0.004 | 0.16 | GABA B receptor agonist | 0.101 0.016 CID_154699485 | ||
| 0.186 | 0.031 | 0.186 | CF transmembrane conductance regulator agonist | |||
| 0.194 | 0.039 | 0.194 | Hexokinase inhibitor | |||
| 0.176 | 0.022 | 0.176 | UDP-glucose 4-epimerase inhibitor | |||
| 0.159 | 0.009 | 0.159 | Leukotriene antagonist | 0.11 0.018 CID_154699485 | ||
| 0.157 | 0.008 | 0.176 | HIV-1 integrase inhibitor | 0.176 0.005 CID_154699485 | CID_154699485 | |
| 0.16 | 0.011 | 0.16 | Glutamate decarboxylase inhibitor | 0.093 0.034 CID_154699485 | ||
| 0.239 | 0.093 | 0.239 | Gastrin inhibitor | |||
| 0.161 | 0.016 | 0.161 | Electron transport complex I inhibitor | |||
| 0.164 | 0.019 | 0.164 | Creatine kinase inhibitor | 0.102 0.057 CID_154699485 | ||
| 0.179 | 0.035 | 0.249 | Protein-tyrosine phosphatase 1B inhibitor | 0.249 0.017 CID_154699485 | CID_154699485 | |
| 0.174 | 0.031 | 0.174 | Antibacterial (Helicobacter pylori) | 0.132 0.064 CID_154699485 | ||
| 0.167 | 0.026 | 0.167 | Bronchodilator | |||
| 0.233 | 0.093 | 0.233 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.144 | 0.005 | 0.145 | Leukotriene B4 antagonist | 0.145 0.005 CID_154699485 | CID_154699485 | |
| 0.227 | 0.088 | 0.227 | Calpain inhibitor | |||
| 0.163 | 0.024 | 0.163 | Heat shock protein 70 antagonist | |||
| 0.307 | 0.172 | 0.307 | MAP kinase 1 inhibitor | |||
| 0.154 | 0.021 | 0.154 | Urease inhibitor | |||
| 0.168 | 0.035 | 0.168 | Cyclooxygenase 3 inhibitor | |||
| 0.142 | 0.012 | 0.142 | Vanilloid agonist | 0.119 0.019 CID_154699485 | ||
| 0.153 | 0.022 | 0.153 | Estrogen antagonist | 0.109 0.077 CID_154699485 | ||
| 0.15 | 0.019 | 0.15 | Phosphodiesterase 4D inhibitor | |||
| 0.135 | 0.005 | 0.135 | Potassium channel Kv1.3 blocker | |||
| 0.169 | 0.04 | 0.169 | DNA polymerase I inhibitor | |||
| 0.136 | 0.009 | 0.136 | Glycine receptor agonist | 0.082 0.036 CID_154699485 | ||
| 0.177 | 0.052 | 0.177 | NOS3 expression enhancer | 0.12 0.116 CID_154699485 | ||
| 0.133 | 0.009 | 0.133 | Purinergic P2X1 antagonist | 0.067 0.035 CID_154699485 | ||
| 0.179 | 0.056 | 0.179 | Interleukin 6 antagonist | |||
| 0.146 | 0.024 | 0.146 | Androgen antagonist | |||
| 0.18 | 0.058 | 0.18 | ATPase inhibitor | |||
| 0.125 | 0.005 | 0.125 | Leukotriene D4 antagonist | |||
| 0.137 | 0.019 | 0.137 | Estrogen receptor beta antagonist | 0.103 0.059 CID_154699485 | ||
| 0.243 | 0.128 | 0.615 | Angiogenesis inhibitor | 0.615 0.015 CID_154699485 | CID_154699485 | |
| 0.121 | 0.006 | 0.121 | Heat shock protein 90 beta antagonist | |||
| 0.121 | 0.007 | 0.121 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.065 0.025 CID_154699485 | ||
| 0.156 | 0.043 | 0.156 | Alkylator | 0.142 0.051 CID_154699485 | ||
| 0.183 | 0.07 | 0.183 | Amyloid beta precursor protein antagonist | |||
| 0.12 | 0.011 | 0.12 | Xanthine dehydrogenase inhibitor | |||
| 0.14 | 0.031 | 0.14 | Potassium channel (Ca-activated) activator | |||
| 0.149 | 0.041 | 0.149 | Topoisomerase I inhibitor | 0.096 0.073 CID_154699485 | ||
| 0.168 | 0.065 | 0.168 | Neurotensin receptor agonist | |||
| 0.176 | 0.074 | 0.176 | Lipocortins synthesis antagonist | |||
| 0.188 | 0.087 | 0.188 | Insulin sensitizer | |||
| 0.162 | 0.061 | 0.162 | Cyclooxygenase inhibitor | 0.12 0.099 CID_154699485 | ||
| 0.138 | 0.039 | 0.138 | Butyrylcholinesterase inhibitor | |||
| 0.112 | 0.014 | 0.112 | Estrogen-related receptor beta agonist | |||
| 0.125 | 0.028 | 0.125 | Carbonic anhydrase VI inhibitor | 0.124 0.028 CID_154699485 | ||
| 0.139 | 0.042 | 0.139 | Falcipain 3 inhibitor | |||
| 0.11 | 0.016 | 0.111 | Aldose reductase inhibitor | 0.111 0.016 CID_154699485 | CID_154699485 | |
| 0.115 | 0.02 | 0.115 | Estrogen receptor alpha antagonist | |||
| 0.123 | 0.032 | 0.123 | Alcohol dehydrogenase inhibitor | |||
| 0.098 | 0.007 | 0.098 | Transcription factor RelA inhibitor | |||
| 0.097 | 0.007 | 0.097 | Glucose-6-phosphate translocase inhibitor | |||
| 0.102 | 0.012 | 0.102 | Transcription factor AP-1 inhibitor | |||
| 0.103 | 0.015 | 0.103 | Beta adrenoreceptor antagonist | |||
| 0.132 | 0.046 | 0.132 | TRPA1 agonist | 0.111 0.071 CID_154699485 | ||
| 0.09 | 0.004 | 0.09 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.14 | 0.055 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.121 | 0.037 | 0.121 | Prolactin inhibitor | |||
| 0.121 | 0.038 | 0.143 | Anabolic | 0.143 0.022 CID_154699485 | CID_154699485 | |
| 0.109 | 0.026 | 0.109 | Purinergic P2X2 antagonist | 0.086 0.037 CID_154699485 | ||
| 0.201 | 0.119 | 0.295 | Immunostimulant | 0.295 0.08 CID_154699485 | CID_154699485 | |
| 0.106 | 0.025 | 0.272 | Carbonic anhydrase V inhibitor | 0.272 0.004 CID_154699485 | CID_154699485 | |
| 0.104 | 0.024 | 0.104 | Leukotriene synthesis inhibitor | |||
| 0.085 | 0.005 | 0.085 | Catechol O-methyltransferase inhibitor | 0.046 0.01 CID_154699485 | ||
| 0.099 | 0.018 | 0.099 | Alcohol oxidase inhibitor | |||
| 0.104 | 0.023 | 0.199 | Carbonic anhydrase VA inhibitor | 0.199 0.005 CID_154699485 | CID_154699485 | |
| 0.105 | 0.025 | 0.105 | Histone deacetylase stimulant | |||
| 0.105 | 0.025 | 0.105 | Histone deacetylase SIRT1 stimulant | |||
| 0.097 | 0.017 | 0.148 | Neuraminidase (influenza) inhibitor | 0.148 0.008 CID_154699485 | CID_154699485 | |
| 0.226 | 0.148 | 0.4 | Antithrombotic | 0.4 0.049 CID_154699485 | CID_154699485 | |
| 0.119 | 0.042 | 0.119 | Sphingomyelinase inhibitor | |||
| 0.152 | 0.075 | 0.152 | Cholinergic | |||
| 0.126 | 0.051 | 0.126 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.03 | 0.104 | Myeloperoxidase inhibitor | |||
| 0.082 | 0.009 | 0.082 | Vanilloid 2 antagonist | 0.057 0.027 CID_154699485 | ||
| 0.12 | 0.048 | 0.148 | Acetylcholine release stimulant | 0.148 0.018 CID_154699485 | CID_154699485 | |
| 0.106 | 0.033 | 0.106 | Porphobilinogen synthase inhibitor | |||
| 0.149 | 0.076 | 0.149 | Cytidine deaminase inhibitor | |||
| 0.087 | 0.014 | 0.087 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.033 | 0.105 | ATPase (Vacuolar H+) inhibitor | |||
| 0.129 | 0.057 | 0.129 | DNA repair enzyme inhibitor | |||
| 0.108 | 0.036 | 0.108 | NADH dehydrogenase inhibitor | |||
| 0.098 | 0.028 | 0.098 | Lipase inhibitor | |||
| 0.09 | 0.02 | 0.09 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.073 | 0.004 | 0.073 | Leukotriene B4 receptor 1 antagonist | |||
| 0.115 | 0.049 | 0.115 | Toll-Like receptor 4 antagonist | |||
| 0.196 | 0.129 | 0.196 | DNA synthesis inhibitor | |||
| 0.126 | 0.06 | 0.126 | Proteasome inhibitor | |||
| 0.076 | 0.011 | 0.076 | Ryanodine receptor antagonist | |||
| 0.108 | 0.043 | 0.108 | Antineoplastic antibiotic | 0.099 0.047 CID_154699485 | ||
| 0.095 | 0.03 | 0.219 | CDC25A inhibitor | 0.219 0.005 CID_154699485 | CID_154699485 | |
| 0.112 | 0.048 | 0.112 | GABA C receptor rho-1 antagonist | |||
| 0.076 | 0.012 | 0.076 | Dihydroorotate oxidase inhibitor | |||
| 0.1 | 0.037 | 0.1 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 CID_154699485 | ||
| 0.116 | 0.053 | 0.116 | AMP-activated protein kinase stimulant | |||
| 0.127 | 0.064 | 0.127 | Aldehyde dehydrogenase inhibitor | |||
| 0.085 | 0.022 | 0.102 | Neuraminidase inhibitor | 0.102 0.014 CID_154699485 | CID_154699485 | |
| 0.073 | 0.012 | 0.073 | Leukotriene C antagonist | |||
| 0.073 | 0.013 | 0.115 | Adenine nucleotide translocase inhibitor | 0.115 0.004 CID_154699485 | CID_154699485 | |
| 0.08 | 0.02 | 0.08 | Phosphodiesterase 1C inhibitor | |||
| 0.076 | 0.018 | 0.076 | Carbonic anhydrase XIV inhibitor | |||
| 0.115 | 0.058 | 0.115 | GABA C receptor antagonist | |||
| 0.142 | 0.084 | 0.539 | Diuretic | 0.539 0.006 CID_154699485 | CID_154699485 | |
| 0.066 | 0.01 | 0.066 | Dopamine D5 agonist | |||
| 0.096 | 0.041 | 0.096 | Glutathione S-transferase inhibitor | |||
| 0.088 | 0.033 | 0.088 | Phosphodiesterase 5A inhibitor | |||
| 0.111 | 0.056 | 0.111 | GABA C receptor agonist | |||
| 0.092 | 0.038 | 0.092 | Thioredoxin reductase inhibitor | |||
| 0.092 | 0.039 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.102 0.029 CID_154699485 | CID_154699485 | |
| 0.06 | 0.007 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 CID_154699485 | ||
| 0.075 | 0.022 | 0.075 | Phosphodiesterase 4A inhibitor | |||
| 0.108 | 0.056 | 0.194 | Gastric antisecretory | 0.194 0.013 CID_154699485 | CID_154699485 | |
| 0.112 | 0.06 | 0.112 | Protein kinase C gamma inhibitor | |||
| 0.068 | 0.017 | 0.068 | Topoisomerase II beta inhibitor | |||
| 0.062 | 0.011 | 0.062 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.098 | 0.048 | 0.098 | Phosphodiesterase I inhibitor | |||
| 0.08 | 0.033 | 0.08 | Dopamine D1 antagonist | |||
| 0.083 | 0.035 | 0.083 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.083 | 0.038 | 0.083 | Phosphodiesterase V inhibitor | |||
| 0.071 | 0.027 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.07 | 0.026 | 0.261 | Estrogen agonist | 0.261 0.006 CID_154699485 | CID_154699485 | |
| 0.064 | 0.022 | 0.064 | Pregnane X receptor antagonist | |||
| 0.248 | 0.207 | 0.248 | Calcium channel L-type activator | |||
| 0.072 | 0.031 | 0.072 | Beta 3 adrenoreceptor antagonist | |||
| 0.097 | 0.057 | 0.097 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | |||
| 0.08 | 0.041 | 0.08 | Phosphofructokinase-1 inhibitor | |||
| 0.044 | 0.005 | 0.044 | Leukotriene B4 receptor 2 antagonist | |||
| 0.069 | 0.03 | 0.069 | Maillard reaction inhibitor | |||
| 0.073 | 0.034 | 0.073 | Aryl hydrocarbon receptor antagonist | |||
| 0.096 | 0.057 | 0.096 | Uric acid excretion stimulant | |||
| 0.082 | 0.044 | 0.082 | GABA aminotransferase inhibitor | |||
| 0.106 | 0.069 | 0.263 | Multidrug resistance-associated protein 1 inhibitor | 0.263 0.004 CID_154699485 | CID_154699485 | |
| 0.071 | 0.034 | 0.071 | Aromatase inhibitor | |||
| 0.096 | 0.06 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.079 | 0.042 | 0.079 | Phosphodiesterase VI inhibitor | |||
| 0.066 | 0.029 | 0.066 | Beta 2 adrenoreceptor agonist | |||
| 0.101 | 0.065 | 0.101 | Adenylate kinase inhibitor | |||
| 0.052 | 0.017 | 0.052 | Estrogen receptor alpha agonist | |||
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.093 | 0.058 | 0.093 | Thioredoxin inhibitor | |||
| 0.111 | 0.077 | 0.111 | Beta amyloid protein antagonist | |||
| 0.072 | 0.038 | 0.072 | Potassium channel (ATP-sensitive) blocker | |||
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | |||
| 0.084 | 0.051 | 0.127 | Glycine receptor antagonist | 0.127 0.014 CID_154699485 | CID_154699485 | |
| 0.066 | 0.033 | 0.066 | Cyclin D1 inhibitor | |||
| 0.131 | 0.098 | 0.131 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.088 | 0.057 | 0.088 | Calcium antagonist | |||
| 0.066 | 0.035 | 0.066 | Phosphodiesterase 1B inhibitor | |||
| 0.046 | 0.016 | 0.048 | Phosphoglycerate kinase inhibitor | 0.048 0.015 CID_154699485 | CID_154699485 | |
| 0.092 | 0.062 | 0.133 | Protein kinase C zeta inhibitor | 0.133 0.026 CID_154699485 | CID_154699485 | |
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | 0.048 0.023 CID_154699485 | ||
| 0.06 | 0.031 | 0.06 | 5 Hydroxytryptamine 7 agonist | |||
| 0.114 | 0.086 | 0.114 | Cyclooxygenase 2 inhibitor | 0.112 0.09 CID_154699485 | ||
| 0.077 | 0.049 | 0.143 | Catalase inhibitor | 0.143 0.028 CID_154699485 | CID_154699485 | |
| 0.107 | 0.08 | 0.107 | Caspase 3 inhibitor | |||
| 0.134 | 0.107 | 0.134 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR8) agonist | |||
| 0.065 | 0.039 | 0.065 | Calcium channel P-type blocker | |||
| 0.095 | 0.07 | 0.095 | Glutamate (mGluR7) agonist | |||
| 0.206 | 0.182 | 0.206 | Calpain 2 inhibitor | |||
| 0.051 | 0.027 | 0.051 | Carbonic anhydrase VII inhibitor | |||
| 0.071 | 0.048 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.027 | 0.004 | 0.027 | Antibiotic Anthracycline-like | |||
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.145 | 0.125 | 0.145 | I kappa B kinase epsilon inhibitor | |||
| 0.087 | 0.068 | 0.087 | Glutamate release inhibitor | |||
| 0.085 | 0.067 | 0.194 | Triose-phosphate isomerase inhibitor | 0.194 0.012 CID_154699485 | CID_154699485 | |
| 0.028 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | |||
| 0.039 | 0.021 | 0.152 | Estrogen receptor beta agonist | 0.152 0.007 CID_154699485 | CID_154699485 | |
| 0.066 | 0.049 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.049 | 0.032 | 0.049 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.056 | 0.04 | 0.056 | Fatty acid synthase inhibitor | |||
| 0.075 | 0.061 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.035 | 0.022 | 0.035 | Adenosine uptake inhibitor | |||
| 0.061 | 0.049 | 0.061 | CDC25B inhibitor | |||
| 0.049 | 0.036 | 0.049 | Squalene epoxidase inhibitor | |||
| 0.056 | 0.045 | 0.056 | Lipocortins synthesis agonist | |||
| 0.021 | 0.01 | 0.021 | Progesterone receptor B antagonist | |||
| 0.049 | 0.038 | 0.049 | Beta 2 adrenoreceptor antagonist | |||
| 0.049 | 0.038 | 0.049 | Factor III inhibitor | |||
| 0.052 | 0.043 | 0.052 | DNA helicase inhibitor | |||
| 0.067 | 0.057 | 0.067 | Calcium channel L-type blocker | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | |||
| 0.027 | 0.018 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.034 | 0.025 | 0.034 | Tubulin agonist | |||
| 0.039 | 0.031 | 0.039 | Liver X receptor alpha agonist | |||
| 0.015 | 0.007 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.023 | 0.015 | 0.039 | Dopamine D1 agonist | 0.039 0.005 CID_154699485 | CID_154699485 | |
| 0.037 | 0.03 | 0.037 | GABA uptake inhibitor | |||
| 0.136 | 0.129 | 0.136 | Psychostimulant | |||
| 0.065 | 0.06 | 0.16 | Cathepsin G inhibitor | 0.16 0.019 CID_154699485 | CID_154699485 | |
| 0.028 | 0.022 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.024 | 0.02 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 CID_154699485 | ||
| 0.059 | 0.054 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.047 CID_154699485 | CID_154699485 | |
| 0.041 | 0.037 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.02 CID_154699485 | CID_154699485 | |
| 0.087 | 0.083 | 0.087 | Nitric-oxide synthase inhibitor | |||
| 0.024 | 0.021 | 0.024 | Sodium/glucose cotransporter inhibitor | |||
| 0.182 | 0.18 | 0.182 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.078 | 0.075 | 0.078 | mTOR complex 2 inhibitor | |||
| 0.041 | 0.039 | 0.041 | Heme oxygenase inhibitor | |||
| 0.061 | 0.059 | 0.061 | Potassium channel large-conductance Ca-activated activator | |||
| 0.035 | 0.033 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.041 | 0.04 | 0.041 | Neuraminidase (Influenza A) inhibitor | |||
| 0.043 | 0.042 | 0.043 | Plasminogen activator inhibitor antagonist | |||
| 0.048 | 0.049 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 CID_154699485 | CID_154699485 | |
| 0.022 | 0.026 | 0.026 | Thyroid hormone agonist | 0.026 0.018 CID_154699485 | CID_154699485 | |
| 0.109 | 0.117 | 0.233 | Cell wall synthesis inhibitor | 0.233 0.02 CID_154699485 | CID_154699485 | |
| 0.033 | 0.047 | 0.133 | Leukocyte elastase inhibitor | 0.133 0.007 CID_154699485 | CID_154699485 | |
| 0.045 | 0.061 | 0.15 | Carbonic anhydrase inhibitor | 0.15 0.016 CID_154699485 | CID_154699485 | |
| 0.039 | 0.057 | 0.093 | Carbonic anhydrase VB inhibitor | 0.093 0.018 CID_154699485 | CID_154699485 | |
| 0.048 | 0.068 | 0.073 | Sphingosine kinase inhibitor | 0.073 0.022 CID_154699485 | CID_154699485 | |
| 0.033 | 0.058 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.043 CID_154699485 | CID_154699485 | |
| 0.031 | 0.062 | 0.043 | Mannosidase inhibitor | 0.043 0.035 CID_154699485 | CID_154699485 | |
| 0.04 | 0.08 | 0.063 | Heparanase inhibitor | 0.063 0.019 CID_154699485 | CID_154699485 | |
| 0.02 | 0.065 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.006 CID_154699485 | CID_154699485 | |
| 0.033 | 0.095 | 0.117 | Factor IXa inhibitor | 0.117 0.006 CID_154699485 | CID_154699485 | |
| 0.007 | 0.07 | 0.112 | Estrone sulfatase inhibitor | 0.112 0.004 CID_154699485 | CID_154699485 | |
| 0.03 | 0.093 | 0.087 | H+/K+-transporting ATPase inhibitor | 0.087 0.011 CID_154699485 | CID_154699485 | |
| 0.055 | 0.123 | 0.093 | Aminopeptidase B inhibitor | 0.093 0.07 CID_154699485 | CID_154699485 | |
| 0.145 | 0.229 | 0.288 | Beta lactamase inhibitor | 0.288 0.139 CID_154699485 | CID_154699485 | |
| 0.033 | 0.117 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 CID_154699485 | CID_154699485 | |
| 0.094 | 0.191 | 0.307 | Hemostatic | 0.307 0.015 CID_154699485 | CID_154699485 | |
| 0.024 | 0.142 | 0.212 | Selectin antagonist | 0.212 0.01 CID_154699485 | CID_154699485 | |
| 0.012 | 0.135 | 0.066 | Dopamine D2 agonist | 0.066 0.019 CID_154699485 | CID_154699485 | |
| 0.011 | 0.136 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.004 CID_154699485 | CID_154699485 | |
| 0.06 | 0.204 | 0.171 | Thrombolytic | 0.171 0.067 CID_154699485 | CID_154699485 | |
| 0.018 | 0.188 | 0.091 | Elastase inhibitor | 0.091 0.012 CID_154699485 | CID_154699485 | |
| 0.009 | 0.227 | 0.072 | NMDA 2D receptor antagonist | 0.072 0.005 CID_154699485 | CID_154699485 | |
| 0.004 | 0.421 | 0.675 | Cholecystokinin A agonist | 0.675 0.002 CID_154699485 | CID_154699485 | |
| 0.003 | 0.478 | 0.71 | Cholecystokinin agonist | 0.71 0.002 CID_154699485 | CID_154699485 | |
| 0.009 | 0.557 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 CID_154699485 | CID_154699485 | |
| 0.009 | 0.603 | 0.07 | Thrombin inhibitor | 0.07 0.054 CID_154699485 | CID_154699485 | |
| 0.004 | 0.658 | 0.202 | NMDA 2B receptor antagonist | 0.202 0.005 CID_154699485 | CID_154699485 | |
| 0.01 | 0.683 | 0.386 | Anticoagulant | 0.386 0.018 CID_154699485 | CID_154699485 | |
| 0.015 | 0.78 | 0.096 | Nav1.4 sodium channel blocker | 0.096 0.082 CID_154699485 | CID_154699485 | |
| 0.003 | 0.771 | 0.275 | Cholecystokinin A antagonist | 0.275 0.004 CID_154699485 | CID_154699485 | |
| 0.007 | 0.825 | 0.643 | Cholecystokinin B agonist | 0.643 0.002 CID_154699485 | CID_154699485 | |
| 0.003 | 0.845 | 0.195 | Cholecystokinin antagonist | 0.195 0.005 CID_154699485 | CID_154699485 | |
| 0.002 | 0.858 | 0.173 | Cholecystokinin B antagonist | 0.173 0.004 CID_154699485 | CID_154699485 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |